Release of phase IIa clinical data concerning a first-in-class drug for type 2 diabetes treatment Aug. 17, 2018
Targeted drug delivery using humanized Sialyl Tn-specific antibodies for ovarian cancer treatment Aug. 17, 2018
Cabotegravir/rilpivirine regimen shows noninferiority to three-drug regimen for HIV infection Aug. 16, 2018
RSS